




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
MUMBAISILICONVALLEYBENGALURUSINGAPORENEWDELHINEWYORKGIFTCITY
Research
Artificial
IntelligenceinHealthcare
NavigatingRegulatoryFrontiersinIndia
March2025
?NishithDesaiAssociates2025
?NishithDesaiAssociates2024concierge@
?NishithDesaiAssociates2025
Research
Artificial
IntelligenceinHealthcare
NavigatingRegulatoryFrontiersinIndia
March2025
DMSCode:119795.2
?NishithDesaiAssociates2025concierge@
?NishithDesaiAssociates2025
Rankedasthe‘MostInnovativeIndianLawFirm’intheprestigiousFTInnovativeLawyers
AsiaPacificAwardsformultipleyears.Alsorankedamongstthe‘MostInnovativeAsiaPacificLawFirm’intheseeliteFinancialTimesInnovationrankings.
llwwL
%equoliri
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
Disclaimer
ThisreportisacopyrightofNishithDesaiAssociates.Noreadershouldactonthebasisofanystatementcontainedhereinwithoutseekingprofessionaladvice.Theauthorsandthefirmexpresslydisclaimallandanyliabilitytoanypersonwhohasreadthisreport,orotherwise,inrespectofanything,andofconsequencesofanythingdone,oromittedtobedonebyanysuchpersoninrelianceuponthecontentsofthisreport.
Contact
Foranyhelporassistancepleaseemailusonconcierge@
orvisitusat
.
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
Acknowledgements
UttaraJhaveri
uttara.jhaveri@
UttaraisamemberofthePharmaceutical,Healthcare,MedicalDevice,andDigitalHealthTeamatNishithDesaiAssociates.SheholdsanLLM(NationalandGlobalHealth)fromGeorgetownUniversityLawCenter.Shehasadvisedpharmaceuticalcompanies,medicalprofessionals,andmedicaldevicecompaniesonregulatoryandcompliancemattersandhasexperienceinlitigation.
TanyaKukade
tanya.kukade@
TanyaisaseniormemberinthePharmaceutical,Healthcare,MedicalDeviceandDigitalHealthTeamatNishithDesaiAssociates.Additionally,sheisalsoanintegralpartoftheMake-in-Indiapractice
atNishithDesaiAssociates.
Shehasadvisednumerousmultinationalpharmaceuticalandmedicaldevicecompaniesonregulatoryaspectsooflicensing,priceregulation,import,compliances,aswellasintellectualpropertymatters.Shealsohasexperienceincommercialdocumentationandlitigationmattersforpharmaceuticalcompanies,mattersrelatingtotechnologyandmedialaws,andpublicprocurement.
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
EshikaPhadke
eshika.phadke@
EshikaisaLeaderinthePharmaceutical,Healthcare,MedicalDeviceandDigitalHealthTeam
atNishithDesaiAssociates.Shehasextensiveexperienceadvisingmultinationalcompaniesonregulatoryissues,compliances,marketingandpromotionalactivities,productlabellingandclaims,anti-trustrisks,publicprocurement,interactionswithgovernment,andcommercialdocumentation.Inherpreviousrole,Eshikaworkedcloselywithearly-stagestartupstoenablethemtobringtheirproducttomarket,asaresultofwhichshehaspracticalexperiencedealingwiththechallengesthatindustryplayersatvaryingstagesfaceacrosstheproductlifecycle.Shealsohasexperienceworkingwithhospitalsanddoctorstodefendmedicalnegligencesuits.
Dr.MilindAntani
milind.antani@
Dr.MilindAntani,arenownedsurgeonturnedlawyer,headsthePharmaceutical,Healthcare,MedicalDeviceandDigitalHealthpracticeaswellastheFood&Beveragespracticeatmulti-skilled,research-basedinternationallawfirm,NishithDesaiAssociateswhereherepresentshighnet-worthclientsinmattersalliedtoRegulatoryadvice,JVs,M&As,VCandPrivateEquityinvestments,Collaborations,LicensingandCommercialization.HealsoleadsSocialSectorPracticeandrepresentsvariousglobalandnationalfoundationsinIndia.
Dr.Antanicontinuesasanactiveparticipantinhelpingframenationalpoliciesonkeyimpactareas,withinthemedicalfield.
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
Contents
GlossaryofTerms3
5
Introduction
6
ApplicationsofAIinHealthcareandLifeSciences
A.Diagnostics6
B.AutomationofLaboratoryTesting6
C.ClinicalImaging7
D.ClinicalDecisionSupport7
E.PrecisionMedicine7
F.PredictiveModelling7
G.RoboticSurgery8
H.VirtualHealthAssistants8
I.ElectronicHealthRecords8
J.RemoteMonitoring8
K.MentalHealthcare9
L.Research&Development9
M.DrugDiscovery9
N.ClinicalTrialRecruitment10
O.GenomeEditing10
P.Bioinformatics10
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
ApproachtoRegulatingAIinHealthcare:GlobalPerspective11
A.UnitedStatesofAmerica11
B.UnitedKingdom12
C.EuropeanUnion13
14
RegulationofAIforHealthcareinIndia
A.RegulatoryBodies14
B.ApproachestoRegulationofAI15
C.OtherApplicableLaws17
23
ChallengestoRegulationofAIinIndia
I.LicensingRequirements23
II.ClinicalInvestigations23
III.Post-ApprovalChanges24
IV.Labelling24
V.Pricing24
VI.AdvertisingandClaims24
VII.PromotiontoHealthcarePractitioners25
26
RisksandEthicalChallenges
I.BiasandDiscrimination26
II.QualityofData26
III.Doctor-PatientRelationship26
IV.PrivacyandConfidentiality26
V.PhysicianPreparedness27
VI.Cybersecurity27
VII.EnvironmentalImpact27
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
Conclusion28
29
BeyondAI
A.VirtualRealityandAugmentedRealityinMedicalTrainingandEducation29
B.RoboticsinHealthcare30
C.NanotechnologyinDiagnosticImagingandDrugDelivery31
D.3DPrintedOrgans32
E.PredictiveAnalyticsinHealthcare33
F.PersonalizedMedicine34
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
?NishithDesaiAssociates2025Provideduponrequestonly
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
GlossaryofTerms
AbbreviationFullForm
AAEC
AppreciableAdverseEffectonCompetition
AI
ArtificialIntelligence
AR
Augmentedreality
CCI
CompetitionCommissionofIndia
CCPA
CentralConsumerProtectionAuthority
CDSCO
CentralDrugsStandardControlOrganization
CERT-In
IndianComputerEmergencyResponseTeam
ContractAct
IndianContractAct,1872
CPA
ConsumerProtectionAct,2019
DataProtectionRules
InformationTechnologyAct,2000,theInformationTechnology(ReasonableSecurityPracticesandProceduresandSensitivePersonalDataorinformation)Rules,2011
DCA
DrugsandCosmeticsAct,1940
DigitalCompetitionLaw
DigitalCompetitionBill,2024
DMRA
DrugsandMagicRemedies(ObjectionableAdvertisement)Act,1954
DPCO
Drugs(PriceControl)Order,2013
DPDPA
DigitalPersonalDataProtectionAct,2023
EHRs
ElectronicHealthRecords
EU
EuropeanUnion
GED
GenomeEditing
ICMR
IndianCouncilofMedicalResearch
IP
IntellectualProperty
LMPCR
LegalMetrology(PackagedCommodities)Rules,2011
MDR
MedicalDeviceRules,2017
MeitY
MinistryofElectronicsandInformationTechnology
MHRA
MedicinesandHealthcareProductsRegulatoryAgency
ML
MachineLearning
MoHFW
MinistryofHealthandFamilyWelfare
NHA
NationalHealthAuthority
NMC
NationalMedicalCommission
RMP
RegisteredMedicalPractitioner
SaMD
Software-as-a-Medical-Device
SPDI
SensitivePersonalDataorInformation
TelemedicineGuidelines
TelemedicinePracticeGuidelines,2020
TradeSecretsBill
ProtectionofTradeSecretsBill,2024
?NishithDesaiAssociates2025Provideduponrequestonly
5
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
6?NishithDesaiAssociates2025Provideduponrequestonly
GlossaryofTerms
UCMPMDUniformCodeforMarketingPracticesinMedicalDevices
USAUnitedStatesofAmerica
USFDAUSFoodandDrugAdministration
VRVirtualreality
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
Introduction
ArtificialIntelligence(“AI”)istransforminghealthcareglobally,andIndiaisemergingasoneofthemostdynamicregionsadoptingthiscutting-edgetechnology.TheadvancementsinAIhavethepotentialtooptimizepatientcare,streamlineadministrativeprocessesandimprovediseaseidentificationandmitigation.
Withitsvastanddiversepopulation,Indiafacesuniquechallengesinhealthcaredelivery,includingaccesstoqualitycare,ashortageofskilledhealthcareproviders,andtherisingburdenofchronicdiseases.AIhasthepotentialtoaddressthesechallengesbyimprovingtheaccuracyofdiagnoses,enhancingtreatmentplans,streamliningadministrativetasks,andmakinghealthcareservicesmoreaccessibletoremoteandunderservedpopulations.
Thechallengesposedbyanageingpopulation,theincreasingprevalenceofchronicdiseases,andtheescalatingcostsofhealthcarearepromptinggovernments,healthcareprovidersandconsumerstoseekinnovativesolutionsandtransformhealthcaredeliverymodels.TheCovid-19pandemichasforcedthehealthcareindustrytoimplementlarge-scaletransformationsby
integratingdata-driveninsightsintopatientcare.Thepandemichasalsounderscoredtheexistingshortagesinthehealthcareworkforceanddisparitiesinaccesstocare.Thegrowingavailabilityofdiversedatatypes,suchasgenomics,economic,demographic,clinical,andphenotypicdata,combinedwithadvancementsinmobiletechnology,computingcapabilities,anddatasecurityhasthepotentialtofundamentallyreshapehealthcaredeliverymodelsthroughAI-enhancedsystems.1
InIndia,AIhasstartedtorevolutionizevariousaspectsofhealthcare,rangingfromdiagnosticstodrugdiscoveryandpatientcare.ThecountryiswitnessingasurgeinAI-basedstartups,research,andcollaborationsbetweenhealthcareproviders,technologycompanies,andgovern-mentinstitutions,pavingthewayforAI-driveninnovation.Hegovernment’spushforNationalHealthStack,AyushmanBharat,andPradhanMantriJanArogyaYojanaarehelpingcreatethenecessaryecosystemforAI-poweredhealthcareinnovations.
Inthisresearchpaper,wehaveexploredthekeyareasofAIapplicationinhealthcareinthecountry,themannerofregulationofAItoolsandmodelsinthehealthcaresectorinotherjurisdictionsfollowedbytheassessmentofregulatoryframeworksurroundingAIinIndiaatpresent.WehavealsodiscussedthelegalchallengesfacedbythehealthcareindustryinadoptingandapplyingAI.
1Accessibleat:
/34286183/
.
?NishithDesaiAssociates2025Provideduponrequestonly
7
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
8?NishithDesaiAssociates2025Provideduponrequestonly
ApplicationsofAIinHealthcareandLifeSciences
AIisrapidlyreshapingthelandscapeofhealthcareandlifesciencesindustryinIndia,offeringtransformativesolutionstoaddresssomeofthecountry’smostpressinghealthcarechallengesandisunlockingnewfrontiersinresearch,innovation,andhealthcaredelivery.ByleveragingAI’scapabilities,Indiacanmoveclosertoachievinguniversalhealthcoverage,improvingpatientoutcomes,andcreatingamoreefficient,cost-effectivehealthcaresystem.
InthischapterweexplorethediverseapplicationsofAIacrossvarioussectorsofhealthcareandlifesciencesinIndia,includingdiagnostics,telemedicine,personalizedmedicine,acceleratingdrugdevelopment,improvingdiagnostictools,administrativeefficiency,anddrugdiscovery.
A.Diagnostics
TheevolutionofAIhaslongbeenlinkedtothediagnosisandtreatmentofdiseases,withsignifi-cantmilestonesdatingbacktothe1970s.Earlyrule-basedAIsystemsweredesignedtodiagnoseblood-bornebacterialinfectionsanddemonstratedpotentialforaccuratediseasediagnosisandtreatment,theystruggledtogainwidespreadadoptioninclinicalsettingsduetotheirinabilitytomatchtheaccuracyandclinicaljudgmentofhumanhealthcareproviders.1
Intherealmofdiseasediagnosis,amajorareaofAIresearchfocusesonanalysingdiversedatasources,includingdiagnosticimaging,genetictesting,electro-diagnosticprocedures,clinicallaboratoryresults,andphysicalexaminationnotes.
B.AutomationofLaboratoryTesting
AI’simpactonclinicallaboratoriesisalsonotable,especiallyinenhancingefficiencyandprecision.Automatedmethods,suchasthoseusedinbloodcultures,susceptibilitytesting,andmolecularplatforms,havealreadybecomestandardpracticeinmanylaboratories,significantlyimprovingefficiency.TheintegrationofAIintoclinicalmicrobiologylabscouldfurtheroptimizeprocesses,suchasselectingthemostappropriateantibiotictreatments,whichcouldimprovecureratesforinfectiousdiseases.Moreover,AIhasthepotentialtoshortenclinicaltrialdurations,increaseproductivity,andimproveclinicaldevelopmentoutcomes.Onemajorchallengeindrugdevelop-mentisnon-clinicaltoxicity,whichcontributestohighratesofdrugfailuresinclinicaltrials.Advancesincomputationalmodelling,however,areimprovingthepredictionofdrugtoxicity,refiningthedrugdevelopmentprocess.2
1Accessibleat:
/articles/PMC2464549/
.
2Accessibleat:
/publication/355069925_Applications_of_Artificial_Intelligence_AI_in_healthcare
_A_review.
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
ApplicationsofAIinHealthcareandLifeSciences
C.ClinicalImaging
AnotherpromisingapplicationofAIistheautomatedclassificationofclinicalimaging,particu-larlyinradiology.ArecentanalysisofAI-basedmedicaldevicesapprovedintheU.S.andEuropebetween2015and2020revealedthatmorethanhalfwereapprovedforradiologicalapplications.Thistrendisdrivenbythelimitationsofhumanvisioninclinicalimaging.Thedevelopmentofdeeplearningalgorithmstodetecttumoursinmammogramsatearlierstages,leadingtoimproveddiagnosticaccuracyandbettertreatmentoutcomesforbreastcancerpatientsareasolutiontosuchhumanlimitations.Similarly,AIhasshownpromiseindetectinganeurysmslinkedtodiabeticretinopathy,usingdeeplearning-basedunsupervisedlearningtechniques.Researchhasdemon-stratedthatsuchAImodelscanachievestrongdiagnosticaccuracyandcost-effectiveness.
D.ClinicalDecisionSupport
AIassistshealthcareprovidersindiagnosingandtreatingpatientsbyanalyzingmedicalrecords,clinicalguidelines,andthelatestresearch.AI-powereddecisionsupportsystemscansuggestpersonalizedtreatmentplans,predictpatientoutcomes,andhighlightpotentialrisks,helpingtoreduceerrorsandimprovecare.
E.PrecisionMedicine
Precisionmedicineinvolvestailoringmedicaltreatmentsandinterventionstotheindividualcharacteristicsofeachpatient,suchastheirgeneticmakeup,lifestyle,andenvironment.TheintegrationofAIintoprecisionmedicineholdsthepromiseofimprovingdiagnosticaccuracy,treatmentefficacy,andpatientoutcomes.
AIplaysapivotalroleinthisfieldbyanalyzingvastamountsofdata,suchasgenomics,electronichealthrecords,andmedicalimaging,toidentifypatternsthatmaynotbeapparenttohumanclinicians.AI-poweredsystemsprovideclinicianswithevidence-basedrecommendationstailoredtotheindividualpatient’sneeds,helpingtooptimizetreatmentstrategies,reducemedicalerrors,andenhancepatientoutcomes.
F.PredictiveModelling
AImodelscanpredictdiseaserisk,progression,andtreatmentoutcomesbasedonpatient-specificdata.Bylearningfromhistoricalpatientdata,thesemodelsassistcliniciansinmakinginformeddecisionsaboutpreventionandtreatmentplans.
?NishithDesaiAssociates2025Provideduponrequestonly
9
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
10?NishithDesaiAssociates2025Provideduponrequestonly
ApplicationsofAIinHealthcareandLifeSciences
G.RoboticSurgery
AIisusedinroboticsurgicalsystemstoassistsurgeonsinperformingpreciseandminimallyinvasiveprocedures.Robotscanenhancethesurgeon’sprecision,reducehumanerror,andshortenrecoverytimes.AIsystemscanalsoprovidereal-timefeedback,makingsurgerymoreefficientandsafer.
H.VirtualHealthAssistants
AI-drivenvirtualassistants,suchaschatbotsandvoice-basedsystems,providepatientswithmedicalinformation,answerquestions,andofferguidanceonsymptomsandmedications.Theseassistantscanalsoscheduleappointments,remindpatientsaboutmedications,andmonitorchronicconditionsremotely,improvingpatientengagementandcompliance.
I.ElectronicHealthRecords
Inparallel,healthcareorganizationsareincreasinglyadoptingAItoautomatelabour-intensive,high-volumerepetitivetasks.AIstartupsandcompaniesareaddressingtheneedfortoolsthatcanhandlethesedemandingactivities.OnesuchadaptationistheanalysisoflargedatasetsfromElectronicHealthRecords(“EHRs”),whichcontainbothstructureddata(i.e.laboratorytestsandprocedures)andunstructureddata(i.e.radiologyreportsanddischargesummaries).ThecomplexityandvarietyofdatawithinEHRsmakethemdifficulttoanalysemanually,butAItechniquesenabletheprocessingofthisinformationtoenhanceunderstandingofthemedicalhistory,geneticmarkers,andfamilyhealthrisksofthepatient.3
J.RemoteMonitoring
AIenablesremotemonitoringofpatientsthroughwearabledevicesandsensorsthattrackvitalsigns,physicalactivity,andotherhealthmetricsinreal-time.AIalgorithmsanalyzethisdatatodetectearlysignsofdeteriorationordiseaseprogression,allowingforearlyinterventionandreducinghospitalreadmissions.
3Accessibleat:
/articles/PMC11141850/
.
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
ApplicationsofAIinHealthcareandLifeSciences
K.MentalHealthcare
Traditionally,mentalhealthcarepractitionersrelyondirectinteractionsandbehavioural
observationstodiagnoseandtreatmentalhealthconditions.However,AI-poweredtoolscanenhancethesecapabilitiesbyassistinginearlydetectionanddiagnosis.Thesetoolscangeneratecustomizedtreatmentplansandprovidecontinuoussupport,bridgingresourcegaps,promotingastigma-freeenvironment,andcomplementingprofessionalexpertise.Inthisway,AIholdspromiseinaddressingtheevolvingchallengesofmentalhealthcare.4
RecentadvancementshavealsoenabledAItodeveloppersonalizedtreatmentplansusingintel-ligentalgorithms.Thesealgorithmsanalysepatientdata,incorporatinggenetic,lifestyle,andenvironmentalfactorstorecommendthemosteffectiveandcost-efficienttreatmentstailoredtoindividuals.Furthermore,AI-powereddigitaltools,suchasvirtualtherapistsandchatbots,havesignificantlyincreasedthescalabilityandaccessibilityoftherapeuticinterventions.5
L.Research&Development
Thebiotechnologysectorgeneratesvastdatasetsthatrequiresophisticatedmethodsforstorage,filtering,andanalysis.TheintegrationofAI-driventechnologies,particularMachineLearning(“ML”)andDeepLearning,istransformingtheefficiency,accuracy,andspeedofresearchanddevelopmentinmedicalbiotechnology.AIcananalysedatafromdiversesources,uncoveringinsightsthatwouldbedifficultforhumanresearcherstoidentify.6ByharnessingthepowerofAI,thebiotechnologyindustryispoisedtomakesignificantstridesinimprovingpatientcare,optimizingtreatmentoutcomes,andboostingtheoverallefficiencyofhealthcaresystems.
M.DrugDiscovery
AIacceleratesthedrugdiscoveryprocessbypredictingtheinteractionsbetweenmoleculesandbiologicaltargets,identifyingnewdrugcandidates,andoptimizingclinicaltrialdesigns.Itcanalsoassistinrepurposingexistingdrugsfornewdiseases,speedingupthedevelopmentoftreat-mentsandreducingcosts.
4Accessibleat:
/doi/epdf/10.2147/RMHP.S461562?needAccess=true
.
5Accessibleat:
/science/article/pii/S2949916X24000525
.
6Accessibleat:
/articles/ai-and-machine-learning-in-biotechnology-a-paradigm.pdf
.
?NishithDesaiAssociates2025Provideduponrequestonly
11
ArtificialIntelligenceinHealthcare—NavigatingRegulatoryFrontiersinIndia
12?NishithDesaiAssociates2025Provideduponrequestonly
ApplicationsofAIinHealthcareandLifeSciences
N.ClinicalTrialRecruitment
AIcanstreamlinetheclinicaltrialprocessbyidentifyingsuitablecandidatesfortrialsbasedonpatientdata,improvingtherecruitmentprocess.Itcanalsomonitortrialdatainreal-time,makingiteasiertodetectproblemsoradjustprotocolsquickly.
O.GenomeEditing
GenomeEditing(“GED”)allowsforgeneticengineeringbyinserting,deleting,modifying,orreplacingthe
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 黨群?jiǎn)T考試題庫(kù)及答案
- 美容行業(yè)連鎖店品牌管理與市場(chǎng)擴(kuò)張方案
- 國(guó)際貿(mào)易合同訂立和履行
- 建立班級(jí)學(xué)習(xí)促進(jìn)機(jī)制的思考計(jì)劃
- 幼兒園廚師烹飪培訓(xùn)內(nèi)容
- 全國(guó)青島版信息技術(shù)七年級(jí)下冊(cè)專題二第3課二、《時(shí)間軸控制》教學(xué)設(shè)計(jì)001
- 環(huán)保型太陽(yáng)能產(chǎn)品生產(chǎn)和銷售合同
- 八年級(jí)地理下冊(cè) 7.4 長(zhǎng)江三角洲區(qū)域的內(nèi)外聯(lián)系教學(xué)設(shè)計(jì)2 (新版)湘教版
- 擴(kuò)大勞務(wù)施工合同
- 前臺(tái)工作中的客戶關(guān)系管理計(jì)劃
- 國(guó)家開放大學(xué)《大學(xué)語(yǔ)文》形考任務(wù)1-5參考答案
- 婚禮執(zhí)事單模板
- 《紅色旅游線路設(shè)計(jì)》
- 設(shè)備出廠檢驗(yàn)報(bào)告
- EXCEL公式進(jìn)行經(jīng)緯度與XY坐標(biāo)的相互轉(zhuǎn)換
- 紫銅材質(zhì)證明
- 妊娠期甲狀腺疾病課件
- 導(dǎo)線的連接精品課件
- 059.商業(yè)計(jì)劃書和可行性報(bào)告精制食油廠年產(chǎn)萬(wàn)噸精制山茶油項(xiàng)目可行性研究報(bào)告
- 米度盾構(gòu)導(dǎo)向系統(tǒng)
- [說(shuō)明]心血管內(nèi)科(心內(nèi)科)_見習(xí)教案_6_動(dòng)脈粥樣硬化和冠狀動(dòng)脈粥樣硬化性心臟病
評(píng)論
0/150
提交評(píng)論